These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2673478)

  • 1. The switch mechanism and the bipolar/unipolar dichotomy.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Br J Psychiatry; 1989 Jan; 154():48-51. PubMed ID: 2673478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switch mechanism in affective illness and oral S-adenosylmethionine (SAM).
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH; Toone BK
    Br J Psychiatry; 1987 May; 150():724-5. PubMed ID: 3651725
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
    Bottiglieri T; Godfrey P; Flynn T; Carney MW; Toone BK; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1096-8. PubMed ID: 2292704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
    Fazio C; Andreoli V; Agnoli A; Casacchia M; Cerbo R
    Minerva Med; 1973 Apr; 64(29):1515-29. PubMed ID: 4576704
    [No Abstract]   [Full Text] [Related]  

  • 6. Open trial of S-adenosylmethionine for treatment of depression.
    Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P
    Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipolar II disorder : epidemiology, diagnosis and management.
    Benazzi F
    CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis.
    Bradley JD; Flusser D; Katz BP; Schumacher HR; Brandt KD; Chambers MA; Zonay LJ
    J Rheumatol; 1994 May; 21(5):905-11. PubMed ID: 8064733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial.
    Murphy BL; Babb SM; Ravichandran C; Cohen BM
    J Clin Psychopharmacol; 2014 Jun; 34(3):413-6. PubMed ID: 24699040
    [No Abstract]   [Full Text] [Related]  

  • 10. Switch and S-adenosylmethionine.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):316-9. PubMed ID: 3052141
    [No Abstract]   [Full Text] [Related]  

  • 11. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of later bipolar disorder in patients with subthreshold symptoms.
    Homish GG; Marshall D; Dubovsky SL; Leonard K
    J Affect Disord; 2013 Jan; 144(1-2):129-33. PubMed ID: 22842021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective illness and S-adenosyl methionine: a preliminary report.
    Carney MW; Edeh J; Bottiglieri T; Reynolds EM; Toone BK
    Clin Neuropharmacol; 1986; 9(4):379-85. PubMed ID: 2425961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
    Altshuler LL; Suppes T; Black DO; Nolen WA; Leverich G; Keck PE; Frye MA; Kupka R; McElroy SL; Grunze H; Kitchen CM; Post R
    Am J Psychiatry; 2006 Feb; 163(2):313-5. PubMed ID: 16449487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania.
    Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):279-90. PubMed ID: 15708427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Mixed hypomania" in children and adolescents: is it a pediatric bipolar phenotype with extreme diurnal variation between depression and hypomania?
    Dilsaver SC; Akiskal HS
    J Affect Disord; 2009 Jul; 116(1-2):12-7. PubMed ID: 19007995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
    Dakhlaoui O; Essafi I; Haffani F
    Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.